SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020286
Filing Date
2024-05-03
Accepted
2024-05-03 16:11:42
Documents
76
Period of Report
2024-03-30

Document Format Files

Seq Description Document Type Size
1 10-Q jan-20240330.htm   iXBRL 10-Q 808365
2 EX-31.1 jan-20240330xexx311.htm EX-31.1 9621
3 EX-31.2 jan-20240330xexx312.htm EX-31.2 9645
4 EX-32.1 jan-20240330xexx321.htm EX-32.1 3658
5 EX-32.2 jan-20240330xexx322.htm EX-32.2 3657
  Complete submission text file 0001628280-24-020286.txt   5751755

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20240330.xsd EX-101.SCH 53073
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jan-20240330_cal.xml EX-101.CAL 71450
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jan-20240330_def.xml EX-101.DEF 276876
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20240330_lab.xml EX-101.LAB 563850
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20240330_pre.xml EX-101.PRE 425266
79 EXTRACTED XBRL INSTANCE DOCUMENT jan-20240330_htm.xml XML 628887
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19621 | Film No.: 24913184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)